Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

BG · Q3 2025 Earnings

Bunge Global

Reported November 5, 2025

30-second summary

30-second take: Bunge cut FY2025 adjusted EPS guidance to $7.30–$7.60 from the $7.75 point estimate held last quarter — a ~$0.30 midpoint reduction blamed on spot customer behavior, biofuel policy paralysis, and a "softer Q4." Q3 adjusted EPS landed at $2.27 with $757M of adjusted total EBIT, and the second-half EPS range of $4.00–$4.25 implies Bunge is signaling Q4 lands well below the Q3 print. Underneath the headline cut, net interest expense guidance nearly doubled to $380–$400M and D&A jumped ~45% to $710M — the post-Viterra capital structure is now visible, and it's heavier than the prior framing implied.

Headline numbers

EPS

Q3 FY2025

$2.27

Revenue

Q3 FY2025

$22.16B

+71.6% YoY

Gross margin

Q3 FY2025

4.8%

Operating margin

Q3 FY2025

1.8%

Key financials

Q3 FY2025

Metric	Q3 FY2025	YoY	Q2 FY2025	QoQ
Revenue	$22.16B	+71.6%	$12.77B	+73.5%
EPS	$2.27	—	$1.31	+73.3%
Gross margin	4.8%	—	5.8%	-99bps
Operating margin	1.8%	—	4.2%	-242bps

Guidance

FY2025 adjusted EPS guidance lowered to $7.30-$7.60 (from $7.75 point estimate) amid macro headwinds, with substantial increases in net interest expense ($380-$400M) and depreciation/amortization ($710M) reflecting post-acquisition impacts.

Guidance is issued for both next quarter and the full year. Both may appear below.

New guidance

Metric	Period	Guide	YoY
Second Half Adjusted EPS	FY 2025	$4.00 to $4.25	—

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Adjusted EPS	FY 2025	$7.75	$7.30 to $7.60	-$0.15 to -$0.45 (midpoint $7.45 vs prior $7.75)	Lowered
Adjusted Annual Effective Tax Rate	FY 2025	21% to 25%	23% to 25%	+2pts at the low end (21% → 23%)	Lowered
Net Interest Expense	FY 2025	$220 to $250 million (lower end)	$380 to $400 million	+$130 to +$180 million (low end: $220M → $380M)	Raised
Depreciation and Amortization	FY 2025	approximately $490 million	approximately $710 million	+$220 million (~45% increase)	Raised

Reaffirmed unchanged this quarter: Capital Expenditures ($1.6 to $1.7 billion)

Segment performance

Q3 FY2025

Segment	Q3 FY2025	YoY
Soybean Processing and Refining	$10.857B	+38.1%
Softseed Processing and Refining	$3.661B	+130.3%
Other Oilseeds Processing and Refining	$1.207B	+13.4%
Grain Merchandising and Milling	$6.428B	+168.2%

Platform metrics

Q3 FY2025

Segment	Q3 FY2025
Soybeans Processed	12,139 thousand metric tons
Soybeans Merchandised	7,246 thousand metric tons
Softseeds Processed	3,129 thousand metric tons
Grain Volumes	24,080 thousand metric tons
FY2025 Adjusted EPS Guidance	$7.30 - $7.60

Profitability

Q3 FY2025

Segment	Q3 FY2025
Adjusted Segment EBIT	$924 million
Adjusted Total EBIT	$757 million

Other KPIs

Q3 FY2025

Segment	Q3 FY2025
Share Repurchases	$545 million

Management tone

Standalone Bunge metrics → "OneBunge" integrated platform → mildly dilutive Viterra with synergies deferred to 2026–2027. Three quarters ago Viterra was a regulatory waiting game, last quarter it was a freshly-closed integration problem with no quantified synergy target, this quarter it is openly "mildly dilutive to the year." Management said "Viterra is mildly dilutive to the year…Not where we eventually want to get to, certainly with the business and as we go after synergies" — a candid downgrade from last quarter's deferral posture. The signal: the integration economics are worse near-term than what was modeled into the original $7.75 framing, and the synergy curve has been pushed right.

Last quarter's "weaker Q3, 30/70 split" framing has hardened into a "softer Q4" call layered on top of an already-weak Q3. "farmers and end consumers remain largely spot, reflecting continued macro trade and biofuel policy uncertainty" — the spot-behavior language that was newly introduced last quarter is now the explicit justification for the EPS cut. What was framed in Q2 as a transitory locking-in problem (Q3 crush margins fixed before the rally) is now structural demand paralysis pending policy resolution.

Margin recovery timing has slipped two quarters. Last quarter management spoke about second-half recovery and a Q4 hockey stick to bridge to $7.75; this quarter the language is "we would like to think that we would start to see that improvement…early 26" and "we don't see back to the 2023 levels…we do see we're at that part of the cycle where it feels like we're at the bottom." Two shifts in one phrase: the recovery is pushed to 2026, and "bottom" is now an explicit framing — which is honest, but the prior quarter's normalization narrative is effectively retired.

The capital structure narrative changed quietly but materially. Last quarter net interest expense was guided to the "lower end" of $220–250M; this quarter it is $380–400M, and D&A jumped from $490M to $710M. These are presented as acquisition mechanics, but they are the dominant arithmetic driver of the EPS cut alongside Q4 softness — and they should have been visible at the July close. The reframing as "post-combination normality" rather than "we underestimated this" is the most defensive piece of the print.

Hedging density is at a multi-quarter high: "based on what we can see today," "subject to various risks and uncertainties," "we would like to think." Versus a typical Bunge call this is materially more uncertainty-laden, consistent with a management team in post-M&A transition managing expectations toward the March 2026 Investor Day mid-cycle reset.

Recurring themes management leaned on this quarter:

Viterra integration as 'OneBungie' operating model with unified decision-making across value chainEarly commercial synergies and execution excellence offsetting Viterra's current mild dilutionPolicy uncertainty (biofuel RVO formula, trade tensions) creating spot market behavior and margin pressureArgentina and Australia geographic expansion enabling global balance and optionality in crush/originationCapital project completion cycle (2026) enabling CapEx normalization and increased capital allocation flexibilityMid-cycle earnings guidance refresh expected March 2026 Investor Day post-Viterra integration

Risks management surfaced:

Biofuel policy clarity delay beyond year-end affecting U.S. soybean oil demand timing and margin recoveryPersistent trade policy uncertainty (Canada-China canola, broader trade tensions) dampening customer demand signalsLa Niña weather risk that could disrupt anticipated large crop harvests globallyIntegration execution complexity (systems, processes, GAAP accounting conversion) requiring ongoing operational liftQ4 softness in soy and soft seed processing segments from spot customer behavior and policy uncertainty

Answers to last quarter's watch list

Combined-company forecast and Viterra synergy quantification — Management did not publish a dollar synergy target with timeline. Instead, they framed Viterra as "mildly dilutive" in 2025, with "a little bit" of synergy benefit by year-end, "bigger jump" in 2026, and "big, big step change" in 2027. The mid-cycle quantified target is deferred to the March 2026 Investor Day.

Continue monitoring

Whether Q3 EBIT made the implied Q4 to hit $7.75 look heroic — It did. The $7.75 point estimate was abandoned. With Q3 adjusted EPS at $2.27 and H2 now guided to $4.00–$4.25, implied Q4 is ~$1.73–$1.98 — a sequential step-down even within the cut guide.

Resolved negatively

US RVO decision and R&SO read-through — Policy clarity did not arrive; management cites "continued macro trade and biofuel policy uncertainty" as the primary driver of the cut. R&SO segment-level EBIT was not separately broken out in the new disclosure framework (segment reporting changed post-Viterra), but the qualitative read is unambiguous: policy paralysis is the binding constraint, and improvement is now expected in early 2026 rather than late 2025.

Resolved negatively

Merchandising adjusted EBIT trajectory — Merchandising as a standalone line is no longer reported the same way under the post-Viterra segment structure (which now splits soybean, softseed, other oilseeds, and grain merchandising/milling). The Q2 watch on a sub-$50M Merchandising EBIT print is no longer directly comparable.

Not resolved

Crush margin lock disclosure for Q4 and 2026 — Management did not quantify forward hedge coverage. The H2 EPS range of $4.00–$4.25 implicitly discloses that Q4 economics are largely set, but the explicit hedge-coverage disclosure didn't come.

Not resolved

What to watch into next quarter

Q4 adjusted EPS print vs. the implied ~$1.73–$1.98 range (= H2 guide $4.00–$4.25 minus Q3 $2.27). A print below $1.73 means the cut guide was still too high; above $1.98 means management front-loaded the bad news

March 2026 Investor Day mid-cycle EPS framework — specifically whether Bunge quantifies Viterra cost synergies with a dollar target and a calendar, ending three quarters of deferral

Whether US RVO clarity arrives in Q4 2025 or pushes into 2026, and the resulting R&SO/biofuel demand signal — management has explicitly tied early-2026 margin recovery to this

Net interest expense run-rate in Q4 — at $380–400M FY guide, the implied Q4 run-rate is meaningful and will inform 2026 modeling; watch whether any of this is refinanced down post-integration

2026 crush margin curve disclosure — Bunge has now twice declined to quantify forward hedge coverage; any disclosure ahead of the March Investor Day would reset the earnings power debate

Share repurchase pace — $545M in Q3 is aggressive; whether this continues into Q4 alongside elevated CapEx ($1.6–$1.7B) and higher interest costs is the cleanest signal of management's confidence in 2026 free cash flow

Sources

Bunge Global Q3 2025 earnings press release (SEC EDGAR, filed November 5, 2025): https://www.sec.gov/Archives/edgar/data/1996862/000162828025049208/epr093020251.htm
Bunge Global Q2 2025 earnings press release (prior-period guide baseline): https://www.sec.gov/Archives/edgar/data/1996862/000199686225000201/epr06302025.htm

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.